The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) is a plasma membrane chloride channel protein that regulates vertebrate fluid homeostasis. The inefficiency of wild type human CFTR protein folding/trafficking is exacerbated by genetic mutations that can cause protein misfolding in the endoplasmic reticulum (ER) and subsequent degradation. This project investigates small changes in protein sequence that can alter the thermal stability of the large multi-domain CFTR protein. We target a conserved 70-residue α-subdomain located in the first nucleotide-binding domain that hosts the common misfolding mutation ΔF508. To investigate substitutions that can stabilize this domain, we constructed chimeras between human CFTR and its closest yeast homolog Yor1p. The α-subdomain of Yor1p was replaced with that of CFTR in Saccharomyces cerevisiae. Cellular localization of green fluorescence protein-tagged Yor1p-CFTR chimeras was analyzed by fluorescence microscopy and quantitative multispectral imaging flow cytometry, steady-state protein levels were compared by SDS-PAGE and protein function probed by a phenotypic oligomycin resistance assay. The chimeras exhibited ER retention in yeast characteristic of defective protein folding/processing. Substitution of seven CFTR α-subdomain residues that are highly conserved in Yor1p and other transporters but differ in CFTR (S495P/R516K/F533L/A534P/K536G/I539T/R553K) improved Yor1p-CFTR chimera localization to the yeast plasma membrane. When introduced into human CFTR expressed in mammalian cells, the same substitutions improve the purified protein thermal stability. This stabilized human CFTR protein will be directly useful for structural and biophysical studies that have been limited by the thermal sensitivity of wild type CFTR. The insights into critical structural residues within CFTR could facilitate development of effective therapeutics for CF-causing mutations.
Introduction
Abnormal protein structural and functional stability contribute to many genetic disorders including Cystic Fibrosis (CF), a disease most common in the Caucasian population (Strausbaugh and Davis, 2007; Riordan, 2008; Cutting, 2015) . Multi-domain membrane proteins fold and assemble in the endoplasmic reticulum (ER) (Kim and Skach, 2012; Farinha and Canato, 2017) . Proper inter-domain and intra-domain contacts are necessary to assemble the native conformation, which is monitored by quality control checkpoints before proteins exit the ER for further maturation in the Golgi (Lukacs and Verkman, 2012) . This project sheds light on small changes in the amino acid sequence of a functional subdomain that can largely affect the thermal stability of a multi-domain chloride channel protein called the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR, ABCC7). About 90% of CF patients inherit at least one CFTR allele with a deletion of residue 508 (Kopito, 1999) . ΔF508 exemplifies how deletion of one amino acid can cause profound conformational destabilization to the 1480 amino acid protein such that 99% misfolds and is targeted for ER retention and degradation (Gelman and Kopito, 2002) . Low temperature and chemical chaperones have been shown to partially rescue the defect in ΔF508 CFTR biogenesis in vitro (Denning et al., 1992; Sato et al., 1996; Zhang et al., 2003) . Rescued ΔF508 CFTR that reaches the plasma membrane still exhibits increased proteolysis, reduced half-life and reduced function at physiological temperature (Lukacs et al., 1993; Heda et al., 2001; Sharma et al., 2001) . Therefore, successful treatment of ΔF508 CFTR may require correcting both the protein trafficking and its instability at the cell surface (Lukacs and Verkman, 2012; He et al., 2015; Farinha and Matos, 2016) .
CFTR evolved in vertebrates and is a unique ATP-binding cassette (ABC) transporter that functions as a chloride/bicarbonate channel rather than an active transporter (Gadsby et al., 2006) . ABC transporters are a functionally diverse family with a common architecture. They are homo-or hetero-dimeric, with each monomer containing a transmembrane domain (TMD1 and TMD2) and a nucleotide-binding domain (NBD1 and NBD2). The TMDs communicate with the NBDs through cytoplasmic extensions called the intracellular loops (ICL). NBDs (~250 residues) are highly conserved among ABC transporters and hydrolyze ATP to produce energy necessary for the transport cycle (Hunt et al., 2013; Cant et al., 2014) . For over two decades, efforts to determine CFTR structure by X-ray crystallography have been hampered by the low stability of full-length wild type CFTR (Meng et al., 2017) . Recently, Chen and co-workers have elucidated structures of wild type human and zebrafish CFTR at~3.4 Å resolution, using cryo-electron microscopy (Zhang and Chen, 2016; Liu et al., 2017; Zhang et al., 2017) . Though this has been a momentous accomplishment in CFTR structural biology, to rationally design new and effective therapeutics for ΔF508 and other CF disease variants, and to shed light on CFTR's gating mechanism, we need higher resolution atomic structures of CFTR in different conformations of the gating cycle. The availability of milligram amounts of stable full-length CFTR protein will advance this goal.
Mutations that thermally stabilize or destabilize isolated NBD1 domain also affect not only the function of full-length CFTR at elevated temperatures but also its cellular trafficking to the plasma membrane (Aleksandrov et al., 2012; He et al., 2015) . F508 lies in a helical subdomain in NBD1 and its deletion disrupts stability of this domain as well as its interaction with other domains (Mendoza et al., 2012; Rabeh et al., 2012) . Previously identified allosteric suppressor mutations of ΔF508 CFTR occur mainly in NBD1. These 'rescue' mutations, when introduced into full-length ΔF508 CFTR, improve trafficking and/or thermal stability with varying efficiencies (Teem et al., 1993 (Teem et al., , 1995 Chang et al., 1999; Ana et al., 2002; Aleksandrov et al., 2010) . To facilitate the discovery of such beneficial/stabilizing mutations in full-length human CFTR, a facile means to assess their effects on CFTR biogenesis and thermal stability is needed. For this purpose, here we describe a chimeric protein tool in a facile yeast expression platform.
Yeast lack a CFTR gene. Human CFTR heterologously expressed in yeast was found to be retained in the ER (Kiser et al., 2001; Fu and Sztul, 2009) . Saccharomyces cerevisiae has thus been an equivocal platform for CFTR expression because it is unclear whether this lower eukaryote can ever produce properly folded CFTR. The closest homolog of CFTR in yeast is yeast oligomycin resistance protein (Yor1p), an ABC transporter in subfamily C. The NBDs of CFTR and Yor1p share a high degree of sequence homology (36% NBD1 identity). Indeed, deletion of the phenylalanine in Yor1p NBD1 (ΔF670) homologous to CFTR F508 has been shown to cause Yor1p destabilization, ER retention and loss of function in yeast similar to the defective biogenesis of ΔF508 CFTR in mammalian cells (Katzmann et al., 1999; Pagant et al., 2007 Pagant et al., , 2010 Louie et al., 2012) . A yeast genetic screen that took advantage of the loss-of-function phenotype of ΔF670 Yor1 helped identify several conserved ΔF508 CFTR modifier genes that influence its biogenesis in mammalian cells (Louie et al., 2012; Veit et al., 2016) .
In the present study, we generated Yor1p chimeras in which subdomain portions of NBD1 were replaced with CFTR sequence pieceby-piece. When expressed in S. cerevisiae, these chimeras were found to be retained in the ER. From sequence alignments, we identified seven amino acids that are highly conserved in Yor1p and other transporters, but not in CFTR. Back-to-consensus substitution of these residues into the Yor1p chimera improved the subcellular localization and drug efflux function. We then introduced these same amino acid substitutions into full-length human CFTR expressed in mammalian cells. They modestly augmented trafficking of CFTR to the cell surface, taken as an indicator of proper CFTR folding and maturation (Peters et al., 2011) . Further, the identified combination of mutations also improved thermal stability of purified human CFTR in vitro. We have successfully employed Yor1p-CFTR chimera in yeast as a valid tool to learn new ways to manipulate CFTR stability. The stabilizing mutation combination identified in this study will shed light not only on the protein sequence-folding relationship but may also be practically used to engineer human CFTR with increased stability, thus facilitating structural and biophysical studies.
Materials and methods

Chimera generation
Wild type S. cerevisiae Yor1 was cloned from plasmid pRS316 (Katzmann et al., 1999) in the pVT expression vector (uracil selection marker), under the control of the constitutive ADH1 promoter (Vernet et al., 1987 ) with a C-terminal GFP tag (Supplemental Fig. S1 , plasmid named as pVT-Yor1). Mutations were introduced in CFTR NBD1 (GenBank KP202880) by PCR, assembled and fused into the Yor1-GFP background to replace NBD1 by homologous recombination in yeast (Bulter and Alcalde, 2003; Joska et al., 2014) . GFP-tagged chimeras were expressed in the S. cerevisiae ΔYor1 deletion strain LMY006 (MATα his leu2-Δ1 lys2-801 am ura3-52, yor1:KANMX) (Pagant et al., 2007) . Empty pVT vector served as control. Surviving colonies were selected on uracil deficient medium, chimeric plasmids extracted, integrity of the open reading frame confirmed by DNA sequencing and plasmids re-transformed into naïve LMY006 yeast (Swartz et al., 2014) . Similarly, genes for GFP-tagged marker proteins, Ste6 (Raymond et al., 1992) , MDR1 (cDNA -CCDS5608.1) and CFTR cloned in the pVT vector were expressed in S. cerevisiae strain JPY201 (MATa ura3 Δste6::HIS3).
Live yeast cell fluorescence microscopy
Cultures were grown to mid-log phase (OD 3-4) at 28°C in minimal uracil deficient selective medium as described (Swartz et al., 2014) .
Just prior to microscopy, cells were pelleted and resuspended in glycerol to limit cell motion. Subcellular localization of the GFPtagged chimeras and marker proteins was determined by fluorescence microscopy with a 63× objective on a Zeiss Axiovert 200 M microscope. Five to ten images were obtained for each sample (n = 3 independent experiments) and figures show representative photomicrographs.
Oligomycin resistance assay
Yeast cultures were grown to mid-log phase in minimal uracil deficient medium containing 10% glycerol. Cultures were diluted 5-fold and oligomycin resistance tested by spotting on YEPG (2% yeast extract, 1% peptone and 3% glycerol) plates containing varying concentrations of oligomycin (0-5 μg/ml) as described (Katzmann et al., 1999) . Yeast cells transformed with pVT vector did not exhibit oligomycin resistance ≥0.12 μg/ml and were used as negative control. Photographs show representative results, and the assays were repeated at least three times with comparable results.
MIFC and image analysis
Yeast expressing GFP-tagged Yor1p-CFTR chimeras were grown in selective media, then synchronized by dilution with fresh media to mid-log phase (OD = 2), and allowed to continue growth for 2 h. Live cells were subjected to MIFC in an Amnis ImageStream X MKII imaging flow cytometer (MilliporeSigma). MIFC allowed image acquisition with identical spatial registry of pixels in the brightfield and GFP fluorescence channels. At least 10 7 events (60× magnification) were collected for each sample, and data was processed in the IDEAS software (MilliporeSigma) as follows. Cells in focus in brightfield images were separated from out-of-focus objects according to the gradient root mean square feature by measuring changes of pixel values. Single cells were then gated from debris and multicellular aggregates according to their aspect ratio (width/height near 1) in plots of area vs. aspect ratio. Masks defining cell surface were created based on brightfield images using Boolean logic to combine or subtract masks. Cell surface fluorescence was computed by calculating fluorescence intensity within the surface mask.
SDS-PAGE
For comparison of Yor1p-CFTR chimera expression levels, 10 ml yeast cultures were grown in minimal selective medium to log phase, lysed with glass beads (Rose et al., 1990) , and crude microsomal membrane fractions were prepared (Lerner-Marmarosh et al., 1999) . Equal amounts of total protein were resolved on 7.5% SDSgels and the GFP-tagged chimeric proteins detected by in-gel fluorescence with a Typhoon imager (excitation: 488 nm) (Drew et al., 2008) . Fluorescent bands were quantitated by densitometry using the public domain application Image J (http://imagej.nih.gov/ij/ index.html) and normalized to total protein Coomassie-Blue R250 staining intensity. To compare levels of mature complex glycosylated CFTR (C band) vs. immature core-glycosylated (B band) on SDS-PAGE (Chang et al., 2008) , Chinese Hamster Ovary (CHO) cells expressing CFTR were lysed with RIPA buffer containing protease inhibitors (25 mM Tris Cl pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 10 μg/ml pepstatin, 2.5 μg/ml E-64, 2.5 μg/ml chymostatin, 10 μg/ml leupeptin, 10 μg/ml benzamidine and 1 mM PMSF). Total proteins were quantitated, equal amounts loaded on a gel and in-gel GFP fluorescence for the C and B bands were quantitated as described above.
Mammalian cell CFTR expression, cell surface quantitation and purification All human CFTR constructs contained a N-terminal His 10 -SUMO*, extracellular 901 Flag (DYKDDDDK), and a C-terminal enhanced GFP tag for ease of detection and purification. The tagged CFTR has previously been shown to exhibit regulated chloride channel activity with only modest alterations in channel conductance and gating kinetics (Hildebrandt et al., 2015) . TRE-SUMO*-CFTR FLAG -EGFP-IRES-Puro lentiviral expression vector-plasmid K3235 (Hildebrandt et al., 2015) was used as backbone for the construction of new CFTR expression vectors. NBD1 fragments with a regulatory insertion deletion (ΔRI) and CFTR fragments containing additional mutations were pieced together by overlap extension PCR (Pogulis et al., 2000) . NBD1 fragments were pieced in the CFTR background by In-fusion cloning (Clontech) and homologous recombination (Zhu et al., 2007) . CHO cell lines were transduced with VSV-G pseudotyped packaged lentiviral vectors containing wild type human CFTR or CFTR containing a deletion of RI (Δ405-436), or ΔRI plus additional mutations (Table I ). The resulting stable cell lines were treated with doxycycline for 24 h to induce CFTR expression and imaged by flow cytometry or harvested as described (Hildebrandt et al., 2015) . CFTR was purified to homogeneity in 0.01% decyl maltose neopentyl glycol (Hildebrandt et al., 2014) . To compare the thermal stability of ATPase function (Hildebrandt et al., 2017) , aliquots of CFTR were pre-incubated 30 min at varying temperature, then supplemented with 0.4 mg/ml dioleoylphosphatidylserine/C 12 E 8 (4:1 w/w). ATP hydrolysis was measured with 0.3 mM α-[
32 P]-ATP (Ketchum et al., 2004; Hildebrandt et al. 2014) . Plots of residual activity vs. preincubation temperature were fitted with 3-parameter sigmoidal equations in SigmaPlot 13.0 to obtain the inflection temperature, which here is called functional Tm (Hildebrandt et al., 2017) .
Statistical analysis
For comparison of multiple groups, one-way analysis of variance (ANOVA) followed by post hoc tests Holmes-Sidak, Fisher LSD or Dunnet's test were performed with SigmaPlot 11. P-value of ≤0.05 was considered significant. Table I . CHO cell lines with the corresponding mutations used in this study
Cell line Name Mutations
Note the distinction between 2PT and PPT mutations; 2PT has S492P and PPT has S495P. To avoid potential confusion between the two mutant combinations, in this report 2PT will appear with an underline.
Results
Trafficking of exogenous ABC transporters in yeast
Previous studies have shown that wild type Yor1p predominantly localized to the S. cerevisiae plasma membrane (Katzmann et al., 1999) . We also observed predominant cell surface localization of GFP-tagged Yor1p (Fig. 1A ). In addition, we noticed significant intracellular fluorescence indicative of vacuolar or other secretory organelle localization. This difference may arise from the different promoters and expression levels between the studies. In contrast to Yor1p, other ABC transporters such as MDR1 or Ste6p localized respectively to the ER or the vacuole (typically appearing as a large compartment, http://yeastgfp. yeastgenome.org/), as shown in Fig. 1B and C. A significant amount of MDR1 is also seen in two types of spatially distinct ER present in yeast: perinuclear ER and cortical or plasma membrane-associated ER (Kuchler and Thorner, 1992) . In yeast, a section of misfolded membrane proteins is retained in the ER in specialized compartments called ER associated complexes (ERAC) that can be detected as one or more brightly fluorescent spots along the perinuclear and/or cortical ER by simple fluorescence microscopy of GFP-tagged proteins Kakoi et al., 2013) . Notably full-length CFTR expressed in S. cerevisiae clearly showed retention in ERAC ( Fig. 1D ) (Fu and Sztul, 2009 ). As we will show below, replacing portions of Yor1p NBD1 with sequence of human CFTR led to retention of the protein in the ER. We were then able to find suppressor mutations that restored cell surface localization of the chimera.
Rationale for construction of Yor1p-CFTR chimeras
NBD structure and function are highly conserved among ABC transporters, yet replacing the entire-NBD1 of Yor1p with that of CFTR may be expected to disrupt the NBD1-TMD and NBD1-NBD2 interfaces. Indeed, replacing much of Yor1p NBD1 with that of CFTR led to its retention in ERAC, indicative of a folding defect (discussed later). We therefore followed a piecemeal approach (Fig. 2) . NBDs have three conserved subdomains: a β-strand sheet (green), an α-helical (blue) and a core ATP-binding subdomain (orange) ( Fig. 2A and C) . In addition, CFTR, Yor1p and a few other ABC transporters have a variable length disordered Regulatory Insertion region (RI, gray) (Lewis et al., 2004) . Unlike the β and core subdomains, the α-subdomain is uninterrupted in primary structure. In 1993 Teem et al. successfully replaced the 64 residue α-subdomain of a yeast mating factor (Ste6p) with that of CFTR. The chimera containing CFTR's α-subdomain retained 12% of wild type Ste6p function while larger replacements had no mating function. The STE6-CFTR α-subdomain chimera was used to identify mutations that when introduced into CFTR ΔF508 improved its defective biogenesis and stability in mammalian cells. The α-subdomain replacement between Ste6p and CFTR has been the largest substitution between ABC transporter homologs so far reported to retain function (Teem et al., 1993) . We generated corresponding Yor1p-CFTR chimeras with α-subdomain replacements (called α and α-S7 chimeras, Fig. 2B ), and expressed these in S. cerevisiae. The GFPtagged mutant chimeras were analyzed for subcellular protein distribution (Fig. 3) , and compared to similarly tagged wild type Yor1p and other localization markers (Fig. 1 ).
Yor1p-CFTR chimeras display ER retention pattern in yeast
Unlike wild type Yor1p, the Yor1p-CFTR α-subdomain chimera exhibited punctate localization mainly adjacent to cell surface and perinuclear (Fig. 3A) areas. These spots are characteristic of misfolded protein sequestered in ERAC structures in S. cerevisiae similar to CFTR (Fig. 1D) . A similar pattern was seen for α-S7 chimera ( Fig. 3B ) for which plasma membrane localization was undetectable.
Misfolded mutant proteins retained in ER often exhibit increased turnover in cells compared to their wild type counterparts (Katzmann et al., 1999; Kiser et al., 2001; Kölling, 2002; Kelm et al., 2004) . Therefore, we employed SDS-PAGE to assess the steady-state protein levels for the chimeras (Fig. 4) . The steady-state expression levels of the Yor1p-CFTR chimeric proteins were variable, and reduced (<30% of wild type Yor1p) for the α-subdomain and α-S7 chimera, consistent with interception by protein quality control mechanisms ( Fig. 3A and B). The prerequisite for oligomycin resistance in yeast is delivery of properly folded Yor1p to the plasma membrane, which may explain why the α and α-S7 Yor1p-CFTR chimeras failed to confer resistance in a qualitative oligomycin resistance assay (Fig. 5) . The first round of chimera generation came as a surprise because, replacing identical sequences between STE6-CFTR (Paddon et al., 1996) and STE6-MDR1 (not shown) did not cause ER retention defects. Thus, CFTR α-subdomain sequences were less compatible with Yor1p than with Ste6p despite having greater sequence similarity to Yor1p.
Known rescue mutations improve α-subdomain chimera localization
From sequence alignments, we identified five substitutions S495P, A534P, I539T, R516K and R553K, which are highly conserved in Yor1p and other ABC transporters, but not found in CFTR (Fig. 6A) . Other studies previously showed that the same five substitutions rescue the trafficking and stability of ΔF508 CFTR at different efficiencies (Teem et al., 1993 (Teem et al., , 1995 Ana et al., 2002; Aleksandrov et al., 2010 Aleksandrov et al., , 2012 . Two of these residues, R516 and R553, reside in RXR motifs that may serve as putative ER retention signals for CFTR (Chang et al., 1999; Hegedus et al., 2006) , but are absent in the other transporters. Secondary structural elements and other elements found in CFTR (Lewis et al., 2004) . β-strands S1-S10 are represented by arrows, and α-helices H1-H9 by cylinders. These are colored blue, green or orange according to the α, β and core subdomains shown in (B and C). The locations of highly conserved functional elements involved in ATP-binding and hydrolysis are shown in pink; these include Walker A and B motifs, Signature sequence, and Q and H loops. F508 is in red, and the RI is in gray. (B) Schematic of Yor1p NBD1 sequence (yellow) and the portions replaced with homologous CFTR sequence in the full-length Yor1p-CFTR chimeras. Boundaries of subdomain replacements were as follows: α F494-L558; α-S7 F494-Y577; β E391-G404, G437-R450, S478-S485; Core H7-H8 M607-N635; Core H6, H7-H8 V580-M595, M604-N635; NBD1 E391-S485, F494-N635; ΔRI 405-436. Yor1p residues substituted in the chimeras are numbered according to CFTR residues (S495P, R516K, F533L, K536G, A534P, I539T, R553K and G544R). (C) Human NBD1 3D structure-2PZE (Fig. 2) . α-subdomain replacement chimeras are shown in panels A and B. Chimeras in panels C through J were based on the α-S7 parent shown in panel B, with certain loci reverted back to Yor1p residues. Panels K, L and M show localization for chimeras in which the β-subdomain or portions of the nucleotide-binding core were replaced with CFTR subdomains. In panels N and O, more extensive pieces of the α, β subdomain or core were replaced with CFTR sequence. Panels P and Q show chimeras comparable to N and O, with certain loci reverted to Yor1p residues
We hypothesized that reintroducing Yor1p residues in some or all of the five sites could restore the normal trafficking of the α-subdomain chimera. We tested combinations of the five substitutions as follows: S495P, A534P and I539T were combined (PPT) similar to combinations that have previously been validated , while R516K and R553K were combined (KK) as they may interfere with the two known RXR motifs (Chang et al., 1999) . A significant improvement was observed upon introducing the PPT mutations to the α-extension-to-S7 (Fig. 3C) . The chimera showed fewer ERAC spots and more cell surface localization compared to the parent chimera (Fig. 3B) , suggesting that some of the PPT chimera exited the ER and trafficked to the plasma membrane. Restoration of trafficking appeared incomplete, because the surface ring fluorescence was less uniform and weaker than wild type Yor1p. Adding PPT plus KK further improved the localization pattern with fewer ERAC observed (Fig. 3D) . Steady-state protein levels did not significantly increase compared to the parent α chimera (Fig. 4B) . These results suggest that known rescue mutations, PPT together with KK, improve biogenesis of the chimera but it is not clear what percentage of the chimera exits the ER. Since introducing the PPT and KK mutations to the α chimera improved oligomycin resistance (Fig. 5) , at least a portion of the chimeric protein must reach the plasma membrane. On the other hand, weaker oligomycin resistance and low-level steady-state protein levels (indicative of a short cell biological half-life) compared to wild type Yor1p tend to suggest incomplete rescue of the structural defect caused by the CFTR's α-subdomain sequences.
Novel substitutions further improve chimera localization in yeast
Sequence alignments (Fig. 6A) suggested three additional conserved residues that to our knowledge have not been previously investigated: F533L, K536G and G544R (Fig. 6A, red) . We introduced these substitutions into the α-S7 PPT chimera. F533L and K536G were introduced together (named LG) because these occur as a pair in many ABC transporter sequences (Fig. 6A) . G544R (named R) occurs as either R or K in many transporters; and it was introduced separately. In all mutation combinations tested, an overall improvement in cell surface localization was observed (Fig. 3E-J) . Notably, small bright spots adjacent to the cell periphery were observed, resembling those reported for endosomal proteins (Snf7-http://yeastgfp.yeastgenome. org). Steady-state levels of these proteins increased on average but also became more variable (Fig. 4B) such that difference from α-S7 were not statistically significant (P = 0.08). Introducing the R mutation to the α subdomain containing the PPT, PPT LG or PPT KK LG mutations, further improved oligomycin resistance (Fig. 5) . On the other hand, addition of LG to PPT, PPT KK, PPT R or PPT KK R appeared to weaken the resistance (Fig. 5) . The opposite effects of the R and the LG mutations on resistance may reflect differing influences In-gel fluorescence of the GFP-tagged Yor1p protein band (shown in A) was quantitated by densitometry, and normalized to total Coomassie stained protein as loading control. Averages ± SD (n = 3) were plotted relative to wild type Yor1p levels. None of the mutant combinations differed significantly from the parent α-S7 chimera. Also, the level of core H7-H8 chimera was indistinguishable from Yor1p, according to one-way ANOVA followed by Fisher's least significant difference test.
on protein function, because chimeras containing either R or LG exhibited similar fluorescence localization pattern (Fig. 3E , H and J) and steady-state protein levels (Fig. 4B) . In order to objectively quantify changes in cell surface expression of the chimera, we performed multispectral imaging flow cytometry (MIFC) (Fig. 7) (Basiji, 2007; Zuba-Surma et al., 2008) . This method provided a way to quantitatively assess and statistically compare localization of the chimeras in yeast cultures that represent heterogeneous populations of cells with different levels of ERACs and cell surface GFP. This analysis demonstrated significantly improved cell surface fluorescence (P = 0.002, Fig. 7A ) for PPT KK LG compared to the parent α-S7 chimera. No significant difference in cell surface fluorescence was observed between α-S7 PPT KK LG and wild type Yor1p. Thus, these novel back-to-consensus substitutions, like previously characterized substitutions, appeared to rescue Yor1p chimera protein folding in yeast sufficient to escape targeting by ER quality control mechanisms.
Consequences of other CFTR NBD1 subdomain replacements into Yor1p
As for the work described above, we used a piece-by-piece approach to engineer the other subdomains of CFTR NBD1 into Yor1p (Fig. 2B) , including the three-stranded β-sheet (Fig. 2B, green) , and all fragments of the core region (Fig. 2B, orange) . Like the α chimera, the β-subdomain chimera showed a punctate localization indicative of ERAC (Fig. 3K) . In contrast, Yor1p chimera substituted with CFTR core H7-H8 exhibited a strong surface fluorescence ring (Fig. 3L ) consistent with cell surface localization of wild type Yor1p. Extending the replacement to include CFTR H6 as well as H7-H8 generated a chimera with a localization pattern (Fig. 3M ) resembling perinuclear ER and plasma membrane/ER proteins (http://yeastgfp. yeastgenome.org, organelle: ER). These include membrane proteins such as human MDR1 (Fig. 1C) that are known to retain function in yeast (Kuchler and Thorner, 1992) .
Finally, we combined the fragments to generate a chimera that has most of the CFTR NBD1 sequences except for Q-loop and upstream sequences that are thought to interact with the ICL connections (He et al., 2008; Pagant et al., 2008) . RI deletion has previously been shown to rescue ΔF508 CFTR processing (Aleksandrov et al., 2010) . Therefore, NBD1 constructs were generated with and without RI (see Fig. 2B ). Both these large NBD1 replacement chimeras localized to ERACs (Fig. 3N and O) . However, introducing the combined mutations PPT KK LG into ΔRI-NBD1 greatly improved localization, relieving Yor1p-CFTR from ERAC spots (Fig. 3Q ) albeit some ERAC accumulation was still observed in a small percentage of cells. The NBD1 ΔRI PPT KK LG chimera did exhibit a weak cell surface ring. MIFC showed no significant difference in cell surface fluorescence between NBD1 and NBD1 ΔRI PPT KK LG (Fig. 7A) . The entire-NBD1 chimeras did not confer oligomycin resistance suggesting an impairment of biogenesis (Fig. 5) . It is therefore not clear whether the Yor1p-CFTR NBD1 chimera reaches the plasma membrane.
It is possible that other NBD1 residues must be reverted to that of Yor1p for the entire-NBD1 chimera to efficiently traffic through the ER. Worth mentioning, substitution of other residues near the N-terminus of Yor1p and conserved in other ABC transporters other than CFTR, A399F, E449K, H484V and S492P, did not further improve localization or function of the ΔRI-NBD1/PPT KK LG chimera (data not shown). It is not evident whether additional NBD1 substitutions can improve the chimera trafficking. It remains a possibility that replacement of Oligomycin resistance conferred by the Yor1p-CFTR chimeras. Yeast cells were serially diluted (5-fold) and spotted on plates containing 0-5 μg/ml oligomycin. α chimera containing the PPT and additional KK/LG/R mutations, and their combinations, conferred resistance at 0.12 μg/ml oligomycin concentration. Growth of these mutants diminished at ≥0.24 μg/ml oligomycin. However, Yor1p and the core H7-H8 chimera conferred resistance even to 5 μg/ml oligomycin.
NBD1 in its entirety may have caused unexpected disruption of critical inter-domain interactions resulting in significant ER retention of the chimeric protein. We decided not to probe this chimera further.
Substitution of Yor1p residues into full-length human CFTR improves thermal stability of protein expressed in mammalian cells
We had identified specific residues in the α-subdomain of CFTR NBD1 that improve folding of Yor1p chimeras, but it is difficult to know whether the finding can be extended to protein stability in other contexts. To explore this concept, we introduced combinations of the PPT, KK and LG substitutions (Table I) into GFPtagged full-length human CFTR (NBD1 mutations were introduced in the wild type human CFTR with an extracellular FLAG epitope, a C-terminal GFP tag and the deletion of RI. The ΔRI backbone was employed as it has been shown to further enhance the biogenesis of full-length wild type and ΔF508 CFTR when combined with other NBD1 mutations.) that was expressed in mammalian cells, where tools for evaluating CFTR surface expression and protein stability are already established (Hildebrandt et al., 2014 (Hildebrandt et al., , 2015 (Hildebrandt et al., , 2017 . In CHO cells, the wild type CFTR traffics to the plasma membrane (Hildebrandt, 2015) , and immunocytochemical staining for an extracellular FLAG epitope showed that trafficking of the new CFTR mutants was similar to wild type CFTR (Supplemental Fig. S2 ). We used flow cytometry to quantify cell Residues highlighted in yellow are absolutely conserved, and those in gray exhibit >50% conservation. The third residue is variable in the RXR motif starting at R516. Previously identified S492P, S495P, A534P, I539T, R516K and R553K rescue mutation sites are in cyan boxes. Red boxes indicate the residues corresponding to F533L K536G and G544R selected in this study for reversion to consensus. Consensus is depicted by size of the residues (bits) using the WebLogo server. Below the figure are the combinations of mutations tested in this study. (B) Human CFTR structure-5UAK with α-subdomain in blue, and Structurally Diverse Region (SDR, 526-547) in purple. Select SDR residues F533, K536 and G544 in red and A534 and I539 in cyan sticks. (C) Zoomed-in view of the α-subdomain (gray) of human CFTR structure (5UAK). SDR residues color coded according to (B).
surface localization of the CFTR mutants in comparison with the ΔRI 2PT. CFTR mutant, an NBD modification that has been shown to strongly stabilize full-length CFTR Hildebrandt et al., 2017) and which undergoes complete maturation and trafficking to the cell surface (See Fig. 2 from Aleksandrov et al. 2015; also Urbatsch, Kappes, et al., unpublished data) . This analysis (Fig. 8A) confirmed that all the CFTR mutant combinations trafficked normally to the cell surface, however no significant differences in cell surface CFTR expression between the mutants was observed. We measured the ratio of complex to core glycosylation (band C/B, Fig. 8B ), an index of CFTR maturation (Benharouga et al., 2002) . The band C/B ratio was higher for PPT KK LG R compared to ΔRI 2PT (P = 0.002).
We then selected the most promising mutation combinations for purification, and analyzed thermal stability and enzymatic activity of the purified proteins. In this assay (Hildebrandt, 2017) , CFTR samples were pre-incubated over a range of temperatures to determine the critical temperature at which ATP hydrolysis activity is lost (Fig. 8C) . We refer to this temperature as functional Tm;
experimentally determined values are shown in Fig. 8D . All four CFTR mutants showed significantly higher functional Tm than wild type CFTR (23.3 ± 0.1°C, P < 0.001), and PPT KK LG (39.0 ± 1.6°C) was also significantly more stable than ΔRI 2PT (32.2 ± 1.9°C, P = 0.004). We conclude that α-subdomain substitutions identified as being beneficial to biogenesis of Yor1p-CFTR chimeras in yeast also improved thermal stability of human CFTR expressed in mammalian cells.
Discussion
The intrinsic instability of wild type human CFTR, particularly NBD1, has been implicated in the low efficiency of full-length CFTR trafficking. This is based in part on the observation that the major CF-causing missense mutation ΔF508 (90% of the population), located in NBD1, causes only minor alterations in the crystal structure of the isolated NBD1 domain (Lewis et al., 2004 (Lewis et al., , 2005 (Lewis et al., , 2010 compared to the wild type but severely decreases the unfolding temperature of the domain by 6-7°C (Protasevich et al., 2010) . Many rescue mutations that restore the domain's thermal stability also improve maturation efficiency of full-length CFTR (Rabeh et al., 2012; He et al., 2015) . Several rescue mutations also increase thermal stability of CFTR channel activity (Wang et al., 2011; Aleksandrov et al., 2012; Liu et al., 2012) . These different lines of investigation collectively suggest that small changes in the NBD1 sequence can largely affect the full-length protein stability. For rational development of pharmacological modulators, there is an urgent need to understand regions of dynamic instability in the protein. We anticipate that identifying CFTR stabilizing mutations may help identify those regions.
Implementing facile yeast screens may provide a useful way to pan through combinations of advantageous CFTR substitutions. Inspired by the pioneering study using the STE6-CFTR chimeric protein in yeast (Teem et al., 1993) , we utilized a Yor1p-CFTR chimera strategy to identify conserved substitutions within NBD1 that improve CFTR stability. Recent studies took advantage of the Yor1p-CFTR homology to identify conserved CFTR residues outside NBD1 (Wei et al., 2014 (Wei et al., , 2016 as well as modifier genes that influence CFTR biogenesis (Louie et al., 2012; Veit et al., 2016) , suggesting that Yor1p-CFTR chimeras may offer accurate predictions on CFTR protein stability. Based on our observation that the majority of the rescue mutations occur in the α-subdomain and many previously identified rescue mutations reflect Yor1p native sequences, we employed a Yor1p-CFTR α-subdomain replacement approach. ER retention of the α-subdomain chimeras suggests that biogenesis of Yor1p, like CFTR, is sensitive to changes in this subdomain. This led us to theorize that NBD1 subdomains of ABC transporter C subfamily (Yor1p, CFTR) are more prone to misfolding due to regions of instability than are subfamily B homologs (Ste6p, MDR1). Therefore, restoration of these conserved Yor1p residues in CFTR NBD1 are expected to improve its trafficking to the cell surface. In our approach, which emphasized protein trafficking to the cell surface, Yor1p expression proved a more suitable model than Ste6p to evaluate potential stabilizing mutations in S. cerevisiae.
Mammalian cell expression platforms have proven more effective for CFTR expression than yeast. Thus, NBD1 residue replacements that alleviated ER retention of Yor1p-CFTR in yeast were validated for CFTR expression in mammalian cells. Diminishing increment in cell surface presentation for additional mutations beyond PPT suggests that the maturation of CFTR may have already reached maximum * * 7 µM efficiency for the CHO expression system. However, the combination ΔRI PPT KK LG produced greater thermal stabilization of the purified protein than previously known NBD1 manipulations such as ΔRI 2PT (Aleksandrov et al., 2012 . We chose to assay ATPase function because, unlike ionic flux assays, the activity can be measured in soluble preparations destined for structural efforts. The mutants employed in this study display ATPase activity similar to wild type CFTR (Supplemental Fig. S3 ) suggesting no significant impairment of protein function by the stabilizing mutations (including ΔRI). Likely, the observed increase in functional Tm may correlate with increased thermal stability of channel function, as has been demonstrated for the individual 2PT mutations (Aleksandrov et al., 2012) . Furthermore, it needs to be emphasized that known NBD1 mutations, identified over the last three decades, occur frequently in specific regions of the NBD1. The earliest attempt to identify rescue mutations using the STE6-CFTR chimera identified four α-subdomain mutations (I539T, G550E, R553M/Q and R555K (Teem et al., 1995) ). Other known rescue mutations (R29K, R516K, R555K, R766K) were found in RXR motifs whose disruption may allow ΔF508 CFTR to escape one of the ER quality control checkpoints (Chang et al., 1999) . Deletion of the intrinsically flexible RI region was later shown to improve CFTR trafficking and stability (Aleksandrov et al., 2010) . Sequence comparison with more stable CFTR orthologs led to the identification of proline substitutions in the dynamic RI, Q-loop and structurally diverse region (SDR) (S422P, S434P, S492P, S495P, A534P, also naming the already identified I539T (Aleksandrov et al., 2012) ). Thus, limiting flexibility of RI, Q-loop and SDR may be key to stability of this protein.
The newly identified LG mutations and the known I539T mutations occur in a flexible loop of α-subdomain which is diverse None of the mutant CFTRs showed statistically significant differences compared to each other and to the ΔRI 2PT, as determined by a one-way ANOVA followed by Dunnet's test. (B) To assay protein maturation, total protein extracts from CHO cells expressing mutant CFTR were resolved by SDS-PAGE, and ratios of complex to coreglycosylated CFTR (band C/B) were measured by densitometry of in-gel fluorescence (a representative gel is shown above the graph). Band intensities from three experiments, normalized to the levels of wild type CFTR (ΔRI), are plotted in the graph. *Indicates a significant increase compared to ΔRI 2PT (P = 0.002) as determined by a one-way ANOVA followed by Dunnet's test. (C) Purified CFTR protein in detergent solution was pre-incubated at different temperatures, then upon addition of lipids and substrate, ATPase activity was measured at 33°C. Activities for each trace were normalized to the value determined for the nondenaturing 11°C pre-treatment. (D) Mean functional Tms determined for mutant CFTR proteins in n ≥ 3 experiments; error bars indicate standard deviations. All the mutant combinations tested exhibited significantly greater functional Tm than wild type CFTR (P < 0.001). *Indicates very significant differences (P < 0.005) compared to the stabilized ΔRI 2PT mutant by one-way ANOVA followed by Holm-Sidak test.
among ABC transporters (SDR, Fig. 6B and C) ; Variability of SDR sequence among ABC transporter paralogs and conservation among the orthologs (not shown), suggests that SDR interacts with the TMD (Schmitt et al., 2003) , and may not tolerate sequence changes for this reason. Previous molecular dynamics studies have suggested that ΔRI deletion and 2PT substitutions may normalize the defective flexibility in the SDR of ΔF508 CFTR (Aleksandrov et al., 2010 (Aleksandrov et al., , 2012 . The occurrence of newly identified F533L, K536G (LG) and known A534P, I539T (two of the 2PT mutations) in the SDR suggests that certain residues within the SDR may play a structural role. We propose that correcting the instabilities in the α-subdomain specifically in the SDR could be an important step to improve human CFTR stability. In a complementary study, single substitutions and their combinations were first introduced into isolated CFTR NBD1 domain, which was purified from E. coli to determine thermal stability using biophysical assays. Valid combinations were then introduced into full-length CFTR expressed and purified from mammalian cells to determine stability of the protein (Urbatsch et al., manuscript in preparation). This rigorous approach depends upon a means to generate candidate substitutions at the outset, and can draw upon results of the yeast chimera strategy. It may be worth applying similar strategies to investigate stabilizing substitutions in ΔF508 CFTR maturation and stability. Identification of mutations which stabilize CFTR can also help accelerate structural and biophysical studies that have been hindered by the low stability leading to aggregation tendency of this challenging protein. A similar chimeric approach may be applied to locate stabilizing substitutions for other biomedically relevant human ABC proteins linked to aberrant folding.
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